17641-08-6,MFCD00018900
Catalog No.:AA0024KL

17641-08-6 | 2-Chloro-n-(3-methoxyphenyl)acetamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$79.00   $55.00
- +
5g
97%
in stock  
$211.00   $148.00
- +
10g
97%
in stock  
$361.00   $253.00
- +
25g
97%
in stock  
$710.00 $497.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0024KL
Chemical Name:
2-Chloro-n-(3-methoxyphenyl)acetamide
CAS Number:
17641-08-6
Molecular Formula:
C9H10ClNO2
Molecular Weight:
199.6342
MDL Number:
MFCD00018900
SMILES:
ClCC(=O)Nc1cccc(c1)OC
Properties
Computed Properties
 
Complexity:
175  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
3  
XLogP3:
1.9  

Downstream Synthesis Route

[1]PharmaceuticalChemistryJournal,1981,vol.15,p.849-853    Khimiko-FarmatsevticheskiiZhurnal,1981,vol.15,p.23-26

[2]JournaloftheIndianChemicalSociety,1940,vol.17,p.400,401

[1]OrganicandBiomolecularChemistry,2005,vol.3,p.2129-2139

[2]BioorganicandMedicinalChemistry,2014,vol.22,p.6885-6892

[3]Lettersindrugdesignanddiscovery,2012,vol.9,p.402-408

[4]Patent:EP2322520,2011,A1.Locationinpatent:Page/Pagecolumn24

[5]Patent:JP5714152,2015,B2.Locationinpatent:Page/Pagecolumn29

[6]JournalofMedicinalChemistry,2012,vol.55,p.6391-6402

[7]PharmaceuticalChemistryJournal,1981,vol.15,p.849-853    Khimiko-FarmatsevticheskiiZhurnal,1981,vol.15,p.23-26

[8]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1986,vol.25,p.438-440

[9]ArchivderPharmazie,2013,vol.346,p.793-804

[10]EuropeanJournalofMedicinalChemistry,2020,vol.198

[11]BioorganicandMedicinalChemistry,2004,vol.12,p.3471-3483

[12]JournaloftheAmericanChemicalSociety,1919,vol.41,p.1457

[13]EuropeanJournalofMedicinalChemistry,1985,vol.20,p.187-189

[14]TetrahedronLetters,1998,vol.39,p.7459-7462

[15]MagneticResonanceinChemistry,2000,vol.38,p.384-385

[16]BioorganicandMedicinalChemistry,2006,vol.14,p.4820-4833

[17]JournalofHeterocyclicChemistry,2007,vol.44,p.35-38

[18]JournalofOrganicChemistry,2009,vol.74,p.2846-2849

[19]SyntheticCommunications,2009,vol.39,p.2723-2736

[20]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.2705-2708

[21]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.4661-4664

[22]ChemicalBiologyandDrugDesign,2011,vol.78,p.309-313

[23]LettersinOrganicChemistry,2011,vol.8,p.732-736

[24]BioorganicandMedicinalChemistry,2013,vol.21,p.4332-4341

[25]ChemicalBiologyandDrugDesign,2014,vol.84,p.685-696

[26]BioorganicandMedicinalChemistry,2015,vol.23,p.6173-6184

[27]EuropeanJournalofMedicinalChemistry,2016,vol.107,p.165-179

[28]MonatsheftefurChemie,2016,vol.147,p.565-574

[29]JournalofHeterocyclicChemistry,2016,vol.53,p.1595-1602

[30]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.3679-3683

[31]EuropeanJournalofMedicinalChemistry,2016,vol.123,p.814-821

[32]MedicinalChemistry,2016,vol.12,p.631-639

[33]ArchivderPharmazie,2016,vol.349,p.864-880

[34]JournalofSulfurChemistry,2017,vol.38,p.43-51

[35]MedChemComm,2017,vol.8,p.1421-1434

[36]Arkivoc,2017,vol.2017,p.316-325

[37]ChemicalPapers,2018,vol.72,p.651-659

[38]Molecules,2018,vol.23

[39]BioorganicChemistry,2018,vol.80,p.288-295

[40]JournalofChemicalSciences,2018,vol.130

[41]EuropeanJournalofMedicinalChemistry,2019,vol.165,p.115-132

[42]EuropeanJournalofPharmaceuticalSciences,2019,vol.131,p.177-194

[43]JournalofHeterocyclicChemistry,2019

[44]JournalofHeterocyclicChemistry,2019,vol.56,p.2411-2418

[45]EuropeanJournalofMedicinalChemistry,2019,vol.182

[46]SyntheticCommunications,2019

[47]EuropeanJournalofMedicinalChemistry,2020,vol.196

[48]TetrahedronLetters,2020

[49]BioorganicChemistry,2020,vol.100

[1]JournaloftheIndianChemicalSociety,1940,vol.17,p.400,401

17641-08-6    31523-22-5   
N-(3-Methoxy-phenyl)-2-N'-(5H-1,2,4triazino5,6-bindol-3-yl)-hydrazino-acetamide 

[1]JournaloftheIndianChemicalSociety,1989,vol.66,p.246-247

[1]ChemicalandPharmaceuticalBulletin,1981,vol.29,p.128-136

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:17641-08-6 Molecular Formula|17641-08-6 MDL|17641-08-6 SMILES|17641-08-6 2-Chloro-n-(3-methoxyphenyl)acetamide
Catalog No.: AA0024KL
17641-08-6,MFCD00018900
17641-08-6 | 2-Chloro-n-(3-methoxyphenyl)acetamide
Pack Size: 1g
Purity: 97%
in stock
$79.00 $55.00
Pack Size: 5g
Purity: 97%
in stock
$211.00 $148.00
Pack Size: 10g
Purity: 97%
in stock
$361.00 $253.00
Pack Size: 25g
Purity: 97%
in stock
$710.00 $497.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0024KL
Chemical Name: 2-Chloro-n-(3-methoxyphenyl)acetamide
CAS Number: 17641-08-6
Molecular Formula: C9H10ClNO2
Molecular Weight: 199.6342
MDL Number: MFCD00018900
SMILES: ClCC(=O)Nc1cccc(c1)OC
Properties
Complexity: 175  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 3  
XLogP3: 1.9  
Downstream Synthesis Route
110-89-4    17641-08-6    40297-47-0 

[1]PharmaceuticalChemistryJournal,1981,vol.15,p.849-853    Khimiko-FarmatsevticheskiiZhurnal,1981,vol.15,p.23-26

[2]JournaloftheIndianChemicalSociety,1940,vol.17,p.400,401

536-90-3    79-04-9    17641-08-6 

[1]OrganicandBiomolecularChemistry,2005,vol.3,p.2129-2139

[2]BioorganicandMedicinalChemistry,2014,vol.22,p.6885-6892

[3]Lettersindrugdesignanddiscovery,2012,vol.9,p.402-408

[4]Patent:EP2322520,2011,A1.Locationinpatent:Page/Pagecolumn24

[5]Patent:JP5714152,2015,B2.Locationinpatent:Page/Pagecolumn29

[6]JournalofMedicinalChemistry,2012,vol.55,p.6391-6402

[7]PharmaceuticalChemistryJournal,1981,vol.15,p.849-853    Khimiko-FarmatsevticheskiiZhurnal,1981,vol.15,p.23-26

[8]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1986,vol.25,p.438-440

[9]ArchivderPharmazie,2013,vol.346,p.793-804

[10]EuropeanJournalofMedicinalChemistry,2020,vol.198

[11]BioorganicandMedicinalChemistry,2004,vol.12,p.3471-3483

[12]JournaloftheAmericanChemicalSociety,1919,vol.41,p.1457

[13]EuropeanJournalofMedicinalChemistry,1985,vol.20,p.187-189

[14]TetrahedronLetters,1998,vol.39,p.7459-7462

[15]MagneticResonanceinChemistry,2000,vol.38,p.384-385

[16]BioorganicandMedicinalChemistry,2006,vol.14,p.4820-4833

[17]JournalofHeterocyclicChemistry,2007,vol.44,p.35-38

[18]JournalofOrganicChemistry,2009,vol.74,p.2846-2849

[19]SyntheticCommunications,2009,vol.39,p.2723-2736

[20]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.2705-2708

[21]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.4661-4664

[22]ChemicalBiologyandDrugDesign,2011,vol.78,p.309-313

[23]LettersinOrganicChemistry,2011,vol.8,p.732-736

[24]BioorganicandMedicinalChemistry,2013,vol.21,p.4332-4341

[25]ChemicalBiologyandDrugDesign,2014,vol.84,p.685-696

[26]BioorganicandMedicinalChemistry,2015,vol.23,p.6173-6184

[27]EuropeanJournalofMedicinalChemistry,2016,vol.107,p.165-179

[28]MonatsheftefurChemie,2016,vol.147,p.565-574

[29]JournalofHeterocyclicChemistry,2016,vol.53,p.1595-1602

[30]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.3679-3683

[31]EuropeanJournalofMedicinalChemistry,2016,vol.123,p.814-821

[32]MedicinalChemistry,2016,vol.12,p.631-639

[33]ArchivderPharmazie,2016,vol.349,p.864-880

[34]JournalofSulfurChemistry,2017,vol.38,p.43-51

[35]MedChemComm,2017,vol.8,p.1421-1434

[36]Arkivoc,2017,vol.2017,p.316-325

[37]ChemicalPapers,2018,vol.72,p.651-659

[38]Molecules,2018,vol.23

[39]BioorganicChemistry,2018,vol.80,p.288-295

[40]JournalofChemicalSciences,2018,vol.130

[41]EuropeanJournalofMedicinalChemistry,2019,vol.165,p.115-132

[42]EuropeanJournalofPharmaceuticalSciences,2019,vol.131,p.177-194

[43]JournalofHeterocyclicChemistry,2019

[44]JournalofHeterocyclicChemistry,2019,vol.56,p.2411-2418

[45]EuropeanJournalofMedicinalChemistry,2019,vol.182

[46]SyntheticCommunications,2019

[47]EuropeanJournalofMedicinalChemistry,2020,vol.196

[48]TetrahedronLetters,2020

[49]BioorganicChemistry,2020,vol.100

17641-08-6    109-89-7    40517-65-5 

[1]JournaloftheIndianChemicalSociety,1940,vol.17,p.400,401

17641-08-6    31523-22-5   
N-(3-Methoxy-phenyl)-2-N'-(5H-1,2,4triazino5,6-bindol-3-yl)-hydrazino-acetamide 

[1]JournaloftheIndianChemicalSociety,1989,vol.66,p.246-247

17641-08-6    64-17-5    77775-78-1    77775-79-2    588-16-9 

[1]ChemicalandPharmaceuticalBulletin,1981,vol.29,p.128-136

Building Blocks More >
17689-77-9
17689-77-9
Silanetriol, 1-ethyl-, 1,1,1-triacetate
AA0024VD | MFCD00053703
177259-98-2
177259-98-2
2-(3-(Benzyloxy)phenyl)ethanol
AA002547 | MFCD09926272
177735-11-4
177735-11-4
4-Methyl-3-thiopheneboronic acid
AA0025FH | MFCD04039882
1780-19-4
1780-19-4
1,2,3,4-Tetrahydroquinaldine
AA0025N9 | MFCD00023886
1784-04-9
1784-04-9
N-Alpha-benzoyl-l-arginine methyl ester HCl
AA0025WX | MFCD00038945
1788-10-9
1788-10-9
4-Acetylbenzenesulfonyl chloride
AA00269A | MFCD00800269
179062-06-7
179062-06-7
4,5-Diamino-2-fluorobenzotrifluoride
AA0026ON | MFCD04038250
179472-26-5
179472-26-5
(2R,4S)-tert-Butyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate
AA0026Y6 | MFCD10568357
1798-03-4
1798-03-4
2-(2-Ethylphenoxy)acetic acid
AA00276Q | MFCD03152495
18336-75-9
18336-75-9
4-Isoxazolecarboxylic acid, 5-methyl-3-phenyl-, hydrazide
AA0027G2 | MFCD00119108
Submit
© 2017 AA BLOCKS, INC. All rights reserved.